#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer extensive stage Undifferentiated sarcoma Inflammatory myofibroblastic tumour Leiomyosarcoma Erythema Oesophageal squamous cell carcinoma stage III Mantle cell lymphoma refractory Leiomyosarcoma recurrent Immune-mediated myositis Hypersensitivity pneumonitis Arterial disorder Acute graft versus host disease in intestine Ovarian cancer stage III Cerebellar ataxia Infective uveitis More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Diagnostics Gaucher’s disease type I – Treatment Gaucher’s disease type I Cytokine release syndrome – Trials in Disease Alveolar rhabdomyosarcoma – Basic Information Sjogren’s syndrome – Trials in Disease Sarcoidosis – Life with Disease Mucopolysaccharidosis III Gaucher’s disease type I – Life with Disease Propionic acidaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acp-017 Rifampicin BUDOPRUTUG Erdafitinib Ranibizumab Gad20-209-Fsp-A4 Cobicistat Gallium (68Ga) Gozetotide Upacicalcet Sodium Hydrate ZINC Idursulfase Ondansetron Hydrochloride Pabinafusp Alfa Cholesterol Acetylcholine Chloride Deflazacort Tiratricol Skin Autograft Sodium Ascorbate 4-Hydroxy-N-Desmethyltamoxifen More therapies…

    Learn about Your Condition

    Primary hyperthyroidism Rectal cancer stage III Thyroid cancer metastatic Dermatitis Urinary incontinence Cytokine release syndrome Alcoholism Narcolepsy Malignant melanoma stage III Medulloblastoma Pancreaticoduodenectomy Cutaneous lupus erythematosus Ehlers-Danlos syndrome Hyperlipidaemia Frontotemporal dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Thrombocytopenia

  • A study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy

    Recruiting

    3 1
    Investigated Diseases:
    • Thrombocytopenia
    Bulgaria France Poland Romania Spain

  • Study of romiplostim given before heart surgery in patients with low platelet counts to improve blood clotting after surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Thrombocytopenia
    Investigated Drugs:
    • Romiplostim
    • Sodium Chloride
    France

  • Study on the Effectiveness and Safety of Human Normal Immunoglobulin (IV) for Adults with Chronic Immune Thrombocytopenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thrombocytopenia
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    Czechia Germany Italy Romania Spain

  • Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Thrombocytopenia
    • Myelofibrosis
    Investigated Drugs:
    • Selinexor
    • Pacritinib
    • Ruxolitinib
    Belgium Bulgaria Czechia Denmark France Germany +7

  • A study to compare the absorption of eltrombopag olamine in healthy volunteers to ensure the tablets work the same way for patients with thrombocytopenia or aplastic anemia.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Aplastic anaemia
    • Thrombocytopenia
    Portugal

  • Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thrombocytopenia
    • Breast cancer
    • Non-small cell lung cancer
    Investigated Drugs:
    • Romiplostim
    Greece Poland Portugal Romania Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!